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Abstract 
 South Africa has the highest prevalence of HIV in the world, with young black 
women at greatest risk of infection. New protective biotechnologies continue to be 
developed, including an intravaginal ring (IVR) that releases antiretroviral medications over a 
four-week period. An IVR is currently under development that could protect against HIV, 
STIs, and pregnancy concurrently. However, uptake and adherence to this product is 
unknown. This project explored access and acceptability by interviewing 28 at-risk women 
and men in Cape Town and consulting with five stakeholders. Data revealed that familiarity 
with similar intravaginal products (tampons, female condoms), relationship dynamics, and 
product distribution channels must be considered as IVR products undergo further 
development.	  
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Executive Summary 
 
Black women in South Africa are at the epicenter of South Africa’s human 
immunodeficiency virus (HIV) epidemic, and are also at high risk for sexually transmitted 
infections (STIs) and unplanned pregnancy (Morrow Guthrie et al., 2015). Currently, the only 
methods of dual protection against these health issues are the male and female condom; 
however, these products have not been widely accepted by South African populations 
(Statistics South Africa, 2017). Women continue to struggle to protect themselves as they 
find it difficult to negotiate the use of disease preventative and contraceptive methods in 
male-dominated relationships (Pettifor, Measham, Rees, & Padian, 2004). The introduction 
of a female-initiated intravaginal product could be a potential solution to this issue as the 
discreet nature of the product would allow women to protect themselves without needing to 
negotiate use with their partners. A multipurpose IVR currently being developed at the 
University of Massachusetts Medical School is intended to protect against HIV, gonorrhea, 
and pregnancy simultaneously. However, as the product is still in development and IVRs are 
not yet available in the South African public health sector, it is unclear how it will be 
received by the public. Clinical trials assessing the efficacy of similar IVRs aiming to limit 
HIV infections have not demonstrated accurate levels of efficacy due to varying levels of 
adherence. Therefore, an exploration of the various factors that affect adherence to the 
product is needed to advise its development and introduction in South Africa. 
 The goal of this project was to explore IVR acceptability and accessibility preferences 
within at-risk populations outside of the context of a clinical trial in order to assess promoters 
and barriers to product adherence that may ultimately affect product efficacy. To accomplish 
this, we conducted semi-structured interviews with 28 individuals (22 women and 6 men) 
living in Philippi, a low-income ‘township’ community on the outskirts of Cape Town, South 
Africa, in order to explore individual and community perceptions of the product. The project 
was conducted in collaboration with Sizakuyenza, a non-profit organization based in the 
Philippi township. Five interviews with relevant stakeholders likely to be involved in the 
introduction of the IVR were also conducted to explore the costs, distribution methods, and 
marketing strategies associated with the IVR and related products. 
 Our data, consistent with previous work, suggests that the multipurpose IVR could 
address ongoing concerns around inconsistent condom use (Statistics South Africa, 2017), 
and the influence of relationship dynamics on negotiating the use of various forms of 
Executive	Summary	
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contraception and disease prevention products as well as product acquisition (Pettifor et al., 
2004). Also, consistent with prior observations (Beksinska et al., 2015), our data show 
limited use of intravaginal products including female condoms and tampons in the study 
populations. Limited use of intravaginal products may present an obstacle to the insertion of 
the IVR, as women only have a theoretical understanding of vaginal insertion. Consultations 
with expert stakeholders indicated that this product, much like similar HIV prevention 
products in South Africa such as pre-exposure prophylaxis (PrEP), will likely involve a 
highly regulated release of the product including by prescription only. Such restrictions on 
distribution are likely to influence the use of and adherence to the product, and consequently 
product efficacy. 
 One potential advantage of the IVR is that it can address ongoing concerns 
surrounding inconsistent condom use within relationships, as it would allow partners to no 
longer use condoms, which our data suggest is highly desirable. Another promising feature of 
the product is that it allows women the opportunity (and burden) of managing their disease 
and contraception risk in a more discrete manner. However, our data suggest that many 
participants would still disclose product use to their partners. Some participants raised 
concerns that the discrete nature of the product may lead to concerns of infidelity if a 
relationship partner discovered the female was using the product but had not disclosed it. 
However, the consensus was that the additional protection would be appreciated by both the 
men and women in relationships. 
The effect of various policies, programs, and resources must be considered as possible 
factors affecting IVR use. As a novel product, the IVR may be largely unfamiliar to the at-
risk population, which may lead to misuse or stigmatization of the product. Previous clinical 
trials have recorded women inserting the product periodically to extend product efficacy 
duration or sharing the ring with friends to offer protection to those they perceived to be more 
at-risk at a given moment. Such misuses of the product driven by misconceptions of product 
mechanism of action and efficacy as well as economic limitations will compromise the 
efficacy of the product in its current design. The product requires a constant, low-dose 
exposure to medications to prevent disease and pregnancy. In addition, the association of the 
product with illness and promiscuous behavior, may decrease the willingness of women to 
use the product. To prevent similar instances of misuse and stigmatization, resources will 
need to be allocated towards efforts to inform community members of the product and market 
the product appropriately. From a biotechnology design perspective, product developers may 
need to reconsider the design of the device such that it is more intuitive for users. 
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 This project highlights the importance of the interdisciplinary collaboration between 
social science and technology in the development of a novel medical technology. No matter 
the efficacy of the product, without sufficient uptake and proper adherence among the target 
population, the product will not achieve its intended effectiveness. Therefore, an investigation 
of the social, environmental, economic, and interpersonal factors influencing product 
introduction and uptake is of paramount importance. 
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Introduction 
HIV, gonorrhea, and unplanned pregnancy are three major health concerns in South 
Africa. South Africa is at the center of the global HIV epidemic, with young women 
disproportionately affected by the disease (Morrow Guthrie et al., 2015). In addition to HIV, 
a global study conducted by the World Health Organization (WHO) found that the prevalence 
of gonorrhea in southern Africa is higher compared to other countries studied, with a rate as 
high as 11.6% among women aged 18 to 49 in the Mopani district of the Limpopo province 
of South Africa (Newman et al., 2015). This is particularly concerning as untreated gonorrhea 
increases the risk of HIV infection (Ramjee & Daniels, 2013). Finally, southern Africa has 
the highest rate of unintended pregnancy in Africa and the fourth highest among any region 
in the world, with 55% of all pregnancies in southern Africa occurring unintentionally 
(Sedgh, Singh, & Hussain, 2014). 
The most effective current preventative method for most sexually transmitted 
infections (STIs), HIV, and pregnancy is the male condom. However, the male condom is 
male-initiated, with males, ultimately, having the power to choose to use protection or not. 
Many women are unable to negotiate and initiate condom use, which leads to an increased 
susceptibility to HIV and other STIs (Pettifor et al., 2004). Other preventative methods such 
as birth control pills, female condoms, and microbicides, are also available and used, but 
none have proven highly successful among the South African population. Birth control pills, 
although an effective contraceptive method in some contexts, are not ideal because they are 
unable to protect against HIV and gonorrhea (Planned Parenthood, 2017). In addition, the 
birth control pill requires strict adherence to a set daily regimen in order to be effective. 
Female condoms were introduced as a potential disease preventative method in South Africa, 
but they were unsuccessful as most “[male] partners were not willing to try the method” 
(Beksinska, Rees, McIntyre, & Wilkinson, 2001, p. 676). Microbicides, on the other hand, 
provide a promising solution to preventing HIV. However, the current delivery method for 
the product, a vaginal gel, is not ideal as it needs to be applied once or twice a day and 
requires users to maintain a consistent application regime (Ravel et al., 2012). Currently, a 
female-initiated method combining contraceptive and disease prevention technologies to 
prevent pregnancy, gonorrhea, and HIV does not exist, and could prove highly effective in 
the South African context. 
Introduction	
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The IVR has been developed as a female-initiated contraceptive device. The IVR is 
inserted monthly, with low-dose hormones released gradually into the vagina. This product, 
marketed as the NuvaRing, is not currently available in South African public health sector. 
Clinical trials are currently testing IVR technology for HIV prevention, with the IVR 
releasing antiretroviral (ARV) medications. New developments have considered the 
capabilities of IVR technologies in concurrently releasing hormonal contraception, ARVs for 
HIV prevention, and antibiotics for gonorrhea prevention. Such a device would allow women 
to take the initiative in protecting themselves against unwanted pregnancy, HIV, and 
gonorrhea regardless of the desires or disease states of their partners.  
As the development of the IVR progresses, clinical trials have been conducted in the 
United States and several sub-Saharan African countries to assess the efficacy of the product. 
Topics such as physical characteristics of the ring, insertion methods, drug concentration, and 
impact on the user’s sex life were among the common themes discussed by trial participants 
(Fan et al., 2016). Various trials conducted to assess the efficacy of the product showed high 
acceptability of the product; however, users had concerns such as the ring getting lost in their 
body, inserting it incorrectly, and having to remove the ring for cleaning (Baeten et al., 2016; 
Fan et al., 2016; Montgomery et al., 2012; Nel, Bekker, et al., 2016; van der Straten et al., 
2014). Despite high acceptability, product efficacy has not been accurately measured due to 
adherence-related issues, which these clinical trials failed to explore. Therefore, in order to 
advise the development of the product and its introduction in South Africa, the various 
factors that may affect IVR adherence must be understood. 
Our goal was to explore IVR acceptability and accessibility preferences among at-risk 
populations residing in the Philippi township of Cape Town, South Africa including an 
investigation of the costs, marketing strategies, and distribution methods associated with the 
implementation of the product outside the scope of a clinical trial. In order to accomplish this, 
we explored at-risk women’s perceptions, acceptability, and accessibility preferences of the 
IVR, explored men’s perceptions of the IVR and the influence that these perceptions may 
have on women’s acceptability of the product, and investigated the accessibility of the IVR 
with regards to cost, distribution methods, and marketing strategies.  
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Background 
 
The Intravaginal Ring: A Promising New Technology 
The IVR is a promising new medical technology capable of delivering agents to 
protect women against the transmission of HIV and other STIs and prevent pregnancy 
(Morrow Guthrie et al., 2015). The IVR is described as a “flexible, torus-shaped drug 
delivery system that can easily be inserted and removed by the woman and that provides both 
sustained and controlled drug release, lasting for several weeks to several months” (Thurman, 
Clark, Hurlburt, & Doncel, 2013, p. 696) (see Figures 1 and 2). The most commonly known 
and utilized IVR, the NuvaRing, is a contraceptive vaginal ring that administers a continuous, 
low dose of female hormones to prevent pregnancy, instead of bursts of doses as in injections 
or oral administration, thus minimizing hormonal side effects (Thurman et al., 2013). The 
IVR technology is now expanding to include drugs that can protect users from HIV and other 
STIs. 
 
 
Figure 1. NuvaRing from http://whisperedinspirations.com/wp-content/uploads/2011/09/nuvaring_0.jpg 
 
Figure 2. Variations in participant folding/squeezing techniques for IVR insertion 
 
Utilizing the IVR to prevent HIV and other STIs involves the delivery of sustained 
doses of microbicides, specifically ARVs, in the vagina over an extended duration (Lopez, 
Grimes, Gallo, Stockton, & Schulz, 2013; Nel, van Niekerk, et al., 2016; Thurman et al., 
Acknowledgements	Background	
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2013). This is in contrast to vaginal microbicidal gels, a localized topical technology 
currently in use for HIV prevention, which offer higher rates of delivery in greater quantity 
but require precoital application (Thurman et al., 2013). Pre-exposure prophylactic oral 
therapy for HIV prevention is another method that requires systemic exposure to low and 
continuous doses of ARVs, but requires regular administration (a once daily tablet) that risks 
poor adherence and an increased likelihood of drug resistance (Lopez et al., 2013; Thurman 
et al., 2013). The reduced dosage and localized delivery capable with the IVR limits systemic 
exposure to pharmaceuticals including contraceptive hormonal steroids to prevent pregnancy, 
ARVs for HIV prevention, and other disease preventing pharmaceuticals. As a result, the IVR 
reduces the risk of developing ARV resistance, a common concern with oral dosing and 
microbicidal gels, and has been shown to have fewer hormonal side effects as the first pass 
metabolism in the gut is bypassed (Thurman et al., 2013). Tables 1 and 2 compare the 
features of IVRs and traditional contraceptive and HIV and STI prevention methods. 
 
Table 1. Features of various commonly used contraceptives 
Method Initiator Contraceptive Frequency of Use STI Prevention 
Capability 
Injectable Female Yes 4x per year No 
Pill Female Yes Daily No 
Male Condom Male Yes During Intercourse Yes 
Vaginal Barrier Methods Female Yes During Intercourse Yes 
IVR - NuvaRing Female Yes Monthly No 
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Table 2. Advantages and disadvantages of common STI prevention methods 
Method Advantages Disadvantages 
Male Condom • Effective if used correctly 
• Male initiated 
• Frequently used incorrectly 
• Use stigmatized in “faithful” 
relationships6 
Female 
Condom3 
• Effective if used correctly 
• Female-initiated4 
• Not widely accepted in South 
Africa5 
• Male partners unwilling to use2 
Microbicidal 
Gels1,7 • Female-initiated • Requires frequent application 
IVR7 
• Female-initiated 
• Contraceptive or non-
contraceptive option 
• Not available in South Africa 
• Not effective STI prevention 
method for anal or oral sex 
1(Auslander, Perfect, Breitkopf, Succop, & Rosenthal, 2007) 2(Beksinska et al., 2001) 3(Last, 2007) 4(Martin, Lora, Rochat, & Andes, 2016) 
5(Reproductive Health Matters, 2009) 6(Robinson, 2016) 7(Thurman et al., 2013) 
 
A 2015 study of contraceptive use worldwide found that married or in-union couples 
had a condom usage rate of 4.9% in South Africa, a significantly lower rate than other 
countries in southern Africa such as Botswana (35.8%), Lesotho (16.7%), Namibia (12.3%), 
and Swaziland (21.9%) (United Nations, 2015). Additionally, a 2012 study utilizing 
information from countrywide surveys on unintended pregnancies adapted to be used on a 
worldwide scale found that southern Africa had the highest rate of unintended pregnancy in 
Africa and the fourth highest among any region in the world, with 55% of the total number of 
pregnancies being unintentional (Sedgh et al., 2014). An estimated 7% of South African 
women become unintentionally pregnant even with the use of contraceptives, where 31.9% of 
the unintentional pregnancies occurred while using condoms, 24.9% while using Depo-
Provera shots, and 24.0% while using oral contraceptives (Le, Connolly, Yu, Pinchevsky, & 
Steyn, 2015). 
Compared to traditional contraceptive and STI prevention methods that are currently 
available in South Africa, the IVR presents numerous advantages. Unlike condoms, which 
are male-initiated, the IVR is female-initiated. Combined with the possibility for discreet use, 
the IVR provides women with greater control over their risk of acquiring HIV and STIs or 
becoming pregnant regardless of their partner’s desires or disease statuses (Thurman et al., 
2013). Furthermore, the IVR does not require daily or coital-associated application, as with 
ARVs and microbicidal gels, and provides protection over extended periods of time. Studies 
have shown the IVR to maintain its efficacy for four weeks at a time (Lopez et al., 2013; Nel, 
Bekker, et al., 2016; Nel, van Niekerk, et al., 2016). This allows women to insert the IVR 
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once every four weeks to protect themselves from disease and unplanned pregnancies 
resulting from rape or unplanned sex (Becker et al., 2004; Montgomery et al., 2012). The 
most promising aspect of the IVR, however, is its ability “to deliver more than one 
prevention active pharmaceutical ingredient (API), a concept known as multipurpose 
technologies (MPT)” (Morrow Guthrie et al., 2015, p. 2). By including APIs to prevent 
pregnancies and the transmission of HIV and other STIs, IVRs are able to achieve greater 
efficiency with regards to cost, access, and delivery (Holt & Lusti-Narasimhan, 2013). This 
efficiency stems largely from the capitalization on the demands of the population by “using 
one product type to achieve uptake and use of a second product” (Holt & Lusti-Narasimhan, 
2013, p. 2). 
 This versatility offered by IVRs has presented researchers with the opportunity to 
revolutionize contraceptive and STI prevention technologies through the delivery of other 
localized preventive pharmacology. Researchers at the University of Massachusetts Medical 
School are currently in the process of developing an IVR containing an anti-gonorrhea agent 
in addition to, and independently from, anti-HIV and contraceptive agents. Unlike previous 
IVRs that have only prevented HIV and pregnancy, this particular IVR is able to prevent 
gonorrhea as well. By utilizing a novel approach that targets a specific epitope common 
among various strains of Neisseria gonorrhoeae, this IVR can prevent the transmission of a 
broad range of strains of gonorrhea and reduce the likelihood of the bacteria developing drug 
resistance (Gulati et al., 2013), a crucial addition, as drug resistant strains of gonorrhea have 
emerged (World Health Organization, 2017). This is significant, as gonorrhea and other STIs 
have been shown to increase risk for acquiring HIV due to the resulting inflammatory 
response that compromises the body’s natural defenses. Conversely, people infected with 
HIV are also more likely to acquire STIs (Ramjee & Daniels, 2013; Workowski & Levine, 
2002; World Health Organization, 2017). 
 ARV-based microbicides, the preventive agents employed to prevent HIV, work by 
either blocking the virus from entering the cell (entry or fusion inhibitors), or by preventing 
the replication of the virus (reverse transcriptase inhibitors) (International Partnership for 
Microbicides, 2017b). Current IVRs utilize reverse transcriptase inhibitors such as dapivirine, 
a “highly potent ARV drug” that prevents “HIV from replicating its genetic material after the 
virus enters a healthy cell” (International Partnership for Microbicides, 2017a) and tenofovir 
to interfere with the replication of the virus (International Partnership for Microbicides, 
2017b). Reverse transcriptase inhibitors can be classified into two classes: non-nucleoside 
reverse transcriptase inhibitors (NNRTIs) and nucleoside reverse transcriptase inhibitors 
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(NRTIs) (International Partnership for Microbicides, 2017b). NNRTIs such as dapivirine, as 
explained by the International Partnership for Microbicides (2017a), bind to HIV enzymes, 
thereby blocking initiation sites for the viral replication process and prevent HIV from 
proliferating. NRTIs such as tenofovir, on the other hand, mimic nucleotides, the basic 
building blocks of viral DNA, and incorporate themselves into viral DNA. By doing so, they 
prevent subsequent nucleotides from linking thereby blocking the reverse transcription 
process and, ultimately, inhibiting viral replication (International Partnership for 
Microbicides, 2017b). Figure 3 is an illustration of the phase of the HIV replication process 
that dapivirine and tenofovir inhibit. 
 
Figure 3. ARV-based microbicides work by directly targeting HIV and interfering with one of the phases in the HIV life 
cycle — cell attachment, cell fusion or reverse transcription (International Partnership for Microbicides, 2017b). 
  
 Tenofovir was the first microbicide shown to be effective at preventing HIV 
acquisition in women in the Center for the AIDS Program of Research in South Africa 
(CAPRISA) 004 trial (Thurman et al., 2013). This double-blind, randomized, controlled trial 
comparing the efficacy of tenofovir gel with a placebo gel in sexually active, HIV-uninfected 
women aged 18 to 40 in KwaZulu-Natal, South Africa, found that women with high gel 
adherence had a 54% reduction in HIV acquisition compared to women in the placebo group 
(Abdool Karim et al., 2010). However, despite the efforts of investigators to emphasize gel 
adherence, issues of nonadherence among the study participants affected the trial’s ability to 
accurately predict the efficacy of the tenofovir gel (Abdool Karim et al., 2010). Another 
promising microbicide, dapivirine is in development and is currently in phase IIIb of trials 
(U. S. Department of Health Human Services, 2017). This trial is currently being conducted 
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to “support publication claims and to prepare [for the] launch [of the product]” (Bahadur, 
2008, p. 3). In order to assess the effectiveness of the IVR that releases dapivirine, the clinical 
trial, A Study to Prevent Infection with a Ring for Extended Use (ASPIRE), was launched in 
Uganda, Malawi, Zimbabwe, and South Africa (Baeten et al., 2016). The trial recruited 2,629 
healthy, non-pregnant, HIV-uninfected, sexually active women between the ages of 18 and 
45 and randomly assigned them to either the dapivirine ring or placebo group in a double-
blind test to assess the effectiveness of the IVR in a clinical trial (Baeten et al., 2016). Baeten 
and colleagues (2016) found that there was a 27% reduction in the incidence rate of new HIV 
infections with the use of the IVR, although the relative reduction in HIV incidence was 61% 
for women 25 and older but only 10% among women under the age of 25 (see Figure 4). The 
authors concluded that this stark discrepancy may be the result of both behavioral and 
physiologic factors (Baeten et al., 2016). 
 
	
Figure	4.	Cumulative	incidence	of	HIV	infection	among	women	using	a	placebo	ring	and	a	dapivirine	ring	(Baeten et al., 
2016) 
 
In the ASPIRE study and other similar trials assessing adherence to HIV treatment 
methods and contraceptives conducted in South Africa, persons under 21 years of age have 
shown lower levels of protection compared to persons over 21 years of age (Baeten et al., 
2016; Blanc, Tsui, Croft, & Trevitt, 2009; Evans et al., 2013; Kharsany & Karim, 2015). It 
was speculated that this lower success rate may be due to “physiologic differences in the 
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genital tract of younger women, lower adherence to ring use, more frequent vaginal or anal 
sex, or a combination of these factors” (Nel, van Niekerk, et al., 2016, p. 2140). In order to 
address this dilemma, research must be extended beyond understanding physiological 
differences among different age groups and determining levels of efficacy – an exploration of 
how the product is accepted and may be received by different groups within the target 
population is necessary. Since such a study requires sensitivity to the sociocultural norms of 
the population being studied, a clinical trial environment is not conducive to such an 
exploration. 
 
Young and At-Risk: Characteristics of Women Most Vulnerable to HIV, STIs, 
and Unplanned Pregnancies 
 A survey involving 38,431 South African participants, conducted by the Human 
Sciences Research Council (2014) determined that black females aged 20 to 34 years have a 
significantly higher HIV prevalence (31.6%) than other race, age, and gender groups. The 
survey determined that 15% of the black population in South Africa had HIV, compared to 
0.3% in the white population, 3.1% in the colored population, and 0.8% in the Asian and 
Indian populations (Shisana et al., 2014). The main factors responsible for the discrepancy in 
HIV prevalence by race were determined to be lower marital status and a lower likelihood to 
take preventive methods or treatment than other races (Shisana et al., 2014). To further 
support this, several HIV prevention trials conducted in South Africa also indicated that 
women “under the age of 25 years, having had one STI in the past and being unmarried were 
significantly associated with high risk of HIV seroconversion” (Wand, Whitaker, & Ramjee, 
2011, p. 1). In addition, young women aged 15 to 24 years in South Africa have higher HIV 
incidence rates than their male counterparts, acquiring HIV five to seven years earlier than 
their male peers (Kharsany & Karim, 2015), and young women account for 25% of new 
infections (Shisana et al., 2014). The prevalence of HIV by gender is also markedly different; 
13.3% of females are HIV-positive compared to 4.0% of males, a 3.3-fold difference 
(Statistics South Africa, 2016). Physiologically, women are also at higher risk of contracting 
HIV than men due to the “greater mucosal surface area exposed to pathogens and infectious 
fluid for longer periods during sexual intercourse and are likely to face increased tissue 
injury” (Ramjee & Daniels, 2013, p. 2). 
Relationship dynamics are a known factor in affecting women’s risk for HIV and STI 
infections and pregnancy in South Africa. Dunkle and colleagues (2004) conducted a study of 
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relationship dynamics and risk of HIV infection by interviewing women seeking antenatal 
care at four clinics located in Soweto, South Africa. The study found a significant association 
between controlling behavior and violence from male partners and an increased risk of HIV 
infection (Dunkle et al., 2004). This finding was also supported by a study that surveyed 415 
men and 127 women receiving services from an STI clinic in Cape Town. This study 
revealed that male-dominated relationships were associated with an increased risk of 
acquiring HIV and other STIs (Kalichman et al., 2005). In a national survey on sexual power 
and HIV risk, 11,904 interviews were completed and determined women with low 
relationship control were 2.10 times more likely to use condoms inconsistently, and those 
experiencing forced sex were 5.77 times more likely to use condoms inconsistently compared 
to women with high relationship control (Pettifor et al., 2004). Pettifor and colleagues (2004) 
demonstrated the correlation between women’s lack of sexual power in their relationships 
and their inability to negotiate condom use and other protective measures, was significantly 
associated with higher rates of HIV and STI prevalence. Marital status was an additional 
factor that affected condom use, where the majority of married men and women disapproved 
of condom use in marriage as it encouraged promiscuity and was therefore “unsuitable for 
committed sexual relationships” (Maharaj & Cleland, 2004, p. 120).  
Violence against women is a global problem and another well-recognized risk factor 
for HIV and other STIs (Ackermann & De Klerk, 2002; Higgins, Hoffman, & Dworkin, 
2010). An examination of sexual violence used country-specific studies to determine the 
worldwide prevalence of non-partner violence. The study’s estimates concluded that 
countries in southern sub-Saharan Africa (Namibia, Zimbabwe, and South Africa) had the 
second highest prevalence of non-partner sexual violence in the world (Abrahams et al., 
2014). In 2005, 40% of women in Cape Town reported experiencing sexual assault and one 
in five men openly admitted to perpetrating sexual assault (Kalichman et al., 2005). A study 
of gender-based violence among South African women attending health care clinics found 
that the experience of being sexually assaulted by a male partner was significantly associated 
with increased risk of HIV infection (Dunkle et al., 2004). High-risk behavior was 
demonstrated in an anonymous street intercept survey in South Africa that found that women 
who experienced sexual assault were more likely to have unprotected sex and feared asking 
partners to use condoms (Kalichman et al., 2005). Furthermore, sexual assault of women in 
Cape Town was associated with an increase in high risk behavior such as using shared 
injection drug equipment and pursuing sex work after the sexual assault (Kalichman et al., 
2005). The latter is particularly concerning as female sex workers that provide sexual services 
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in exchange for money, goods, and other benefits, are common in South Africa (Vandepitte et 
al., 2006), and HIV prevalence among sex workers in Cape Town was estimated to be as high 
as 40%, with young female sex workers under 25 years carrying most of the HIV burden 
(Shisana et al., 2014). 
The socioeconomic status of women in South Africa also affects their overall risk of 
contracting HIV and STIs. A national survey of 1.3 million households found that men are 
predominantly the head of the household in every province of South Africa (Statistics South 
Africa, 2016). To support this, interviews with women in Cape Town suggested that men are 
predominantly the primary financial earners and decision makers of the household (Strebel et 
al., 2006). It was found that South African women who depend on the male partners for 
economic stability, lack the socioeconomic power to control sexual negotiations for safer sex 
(Gilbert & Walker, 2002). On the contrary, women who are in a position of generating more 
revenue than the male partner can also stimulate violent conflict as a result of the perceived 
disruption in socially accepted gender roles (Boonzaier, 2005; Strebel et al., 2006). Money 
and material acquisition are also the main factors for women to enter age-disparate 
relationships (adolescent women dating significantly older men) (Leclerc-Madlala, 2008), 
causing women to be put at a substantially higher risk of HIV incidence (Maughan-Brown, 
Kenyon, & Lurie, 2014) and adolescent pregnancy (Toska, Cluver, Boyes, Pantelic, & Kuo, 
2015). 
Stigma is an additional factor in HIV risk that causes women to be reluctant to enact 
HIV prevention (Poundstone, Strathdee, & Celentano, 2004). Also, stigma and fear of status 
disclosure are well-known factors inhibiting individuals seeking treatment (Poundstone et al., 
2004; Pulerwitz, Michaelis, Weiss, Brown, & Mahendra, 2010; UNAIDS, 2012). A survey of 
486 women that measured the result of HIV stigma in South Africa found that HIV positive 
women are subject to gossip (52.3%), verbal harassment (28.3%), exclusion from social 
activities (18.8%), physical assault (15.5%), exclusion from family gatherings (15.5%), and 
exclusion from religious activities (10.3%) (dos Santos, Kruger, Mellors, Wolvaardt, & van, 
2014). Women in South Africa have the heaviest burden of HIV stigma, as being infected 
with HIV is considered failing to uphold moral traditions of their society (Poundstone et al., 
2004). 
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Acceptability of the Intravaginal Ring: The Importance of Factors Beyond 
Product Efficacy 
Given the various socio-ecological factors that increase the risk of women to HIV, 
STIs, and unplanned pregnancies, it is imperative to consider the established sociocultural, 
political, economic, and historical context in order to achieve a seamless integration 
(including correct usage and product adherence) of the IVR. 
The importance of male influence on product use and adherence has been documented 
as an essential component to the success of female-initiated STI prevention methods 
(Montgomery et al., 2011; Montgomery et al., 2015) and has been a topic of discussion in 
many stakeholder conversations (Geary & Bukusi, 2014). In a clinical trial assessing the 
safety and acceptability of a placebo IVR in 170 HIV-negative, African women aged 18 to 
35, 86% of women found their partner’s approval of the IVR to be important; yet, only 78% 
of them disclosed their participation in the study to their partners producing a discrepancy 
between the women’s theoretical desire for their partner’s approval and their actual disclosure 
of information (Montgomery et al., 2012). A similar study of 1,916 participants in Zimbabwe 
and South Africa indicated that women with male partners who “strongly liked” the product 
were two to three times more inclined to like the product themselves and continue using the 
product (Montgomery et al., 2011). 
The influence of various external stakeholders on the introduction of the IVR must 
also be considered. External stakeholders can be divided into two main categories according 
to their role in the implementation of the IVR: policy makers and influentials, and health care 
service providers. Federal, municipal, and local government officials, nongovernmental 
organization (NGO) representatives, research institutions, and professional medical bodies 
comprise the policy makers and influentials category. They are the bodies responsible for 
determining various policies and implementing programs in order to facilitate the successful 
distribution of the product. The health care service providers include public health nurses and 
doctors as well as employees of various reproductive and sexual health facilities. Their 
importance lies in their experience interacting with the at-risk populations that the IVR is 
targeted towards. 
Becker and colleagues (2004) conducted a study in the Western Cape province of 
South Africa to determine the factors that both facilitate and undermine access to and use of 
microbicides. The study involved interviews and focus groups with community members, 
health care providers, government officials, representatives from NGOs, and health 
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professionals (Becker et al., 2004). With regards to distribution, policy makers, providers, 
and community participants all believed that the product should be readily available in 
various locations (Becker et al., 2004). Not only should the product be available in health 
clinics, family planning, well-baby, maternal health, and voluntary counseling and testing 
(VCT) centers, it should also be available in common places where women congregate 
(Becker et al., 2004). A study conducted among 504 women in Ghana assessing the 
acceptability of vaginal microbicides determined that women were most comfortable 
purchasing these products from health-related facilities, and also considered cosmetic shops 
and supermarkets as viable options (Abdulai et al., 2012). In addition, the results indicated 
that women preferred the vendors to be the same age or older and someone they were not 
socially familiar with, suggesting a preference for privacy (Abdulai et al., 2012). Although 
distributing the product in non-health related facilities may increase accessibility, a venue 
where personal counseling on product use is unavailable could pose a potential problem as 
improper or incomplete instructions on the use of the product will encourage improper usage 
and nonadherence, which will compromise the effectiveness of the product. 
Cost is another important factor, as even if the product is easily accessible to clients, it 
also needs to be affordable. According to Becker and colleagues, “national and provincial 
policy makers, key policy informants, and providers all stressed that microbicides should be 
accessible to clients and provided at low cost or free” (2004, p. 4). However, a few factors 
must be taken into consideration when introducing a free product to the health care market. 
Users may feel that the product is inferior if it is being offered for free, and if the health care 
system is going to fund this product there needs to be a strong justification for why this 
product is superior to any other product currently offered on the market (Becker et al., 2004). 
In the study of vaginal microbicide awareness and acceptability in Ghana, an affordable price 
was considered to be between R10 and R20 (0.75-1.50 USD) for each instance of sexual 
interaction (Abdulai et al., 2012). Although substantial government funding will be required, 
the South African government is currently working to increase their contribution to the HIV 
response and are looking into methods to decrease the number of new HIV infections (Health 
Policy Project, 2016). They have created a plan for 2012 to 2016 to reduce new infections by 
at least 50%. In the FY 2016/2017, the government continued to fund the HIV response with 
82.9% of funding coming from the government, 3.8% from the Global Fund, and 13.3% from 
PEPFAR (Health Policy Project, 2016). 
The marketing strategy employed to introduce the product to the market contributes to 
how successfully the product will be adopted as well. In the aforementioned study conducted 
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by Becker and colleagues, community members “cautioned against ‘medicalization’ of the 
product and stressed the need to present products as appealing, fun and ‘normal’” (2004, p. 
53). They believed that users would be more likely to use a product perceived as ‘normal’ 
and associated with a healthy and modern lifestyle rather than one perceived as a medical 
device associated with sickness (Becker et al., 2004). 
Based on previous clinical trials and interviews, a method most likely to successfully 
distribute, fund, and market the IVR can be developed. However, since the multipurpose IVR 
has not been released in South Africa, there are no results on previous attempts at 
implementation specific to the IVR that can be used to develop a plan to introduce the 
product. With the recent approval of PrEP in South Africa, the implementation methods used 
for PrEP might be used as a model to advise the introduction of the IVR. Various clinical 
guidelines have been established to streamline and regulate PrEP distribution. Due to the 
similarity in the purpose of the product as well as the medications being used, these 
guidelines, which detail contraindications, eligibility criteria, and prescription intervals for 
PrEP, might guide distribution of the IVR (National Department of Health, 2016). The cost 
and population-level impact of introducing PrEP to key populations such as female sex 
workers, men-who-have-sex-with-men (MSM), and adolescent girls and young women have 
been determined through mathematical modeling (Gomez et al., 2013). A similar model can 
be developed to predict the costs and population-level impact of the IVR, as well to advise 
the distribution of the IVR to its respective key populations. 
In addition to the various external factors that may affect the reception of the IVR, the 
potential users’ impressions of the physical characteristics of the IVR must be taken into 
consideration. Multiple studies have been conducted to assess potential users’ preferred 
characteristics of an IVR (Becker et al., 2004; Fan et al., 2016; Morrow Guthrie et al., 2015; 
van der Straten et al., 2014). In each of the studies, the women were provided with physical 
samples of IVRs and were asked for their opinions on the characteristics of an ideal IVR and 
what user requirements led them to their decision. The location, study participant 
characteristics, and methods employed to assess the study participants’ thoughts on the IVR 
for each study are shown in Table 3. 
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Table 3. Summary of studies conducted to assess preferred IVR characteristics 
Study Location Study Participants Methods 
Becker 
et al., 
2004 
Langa, Cape Town 
23 focus groups (218 total 
participants), 38 in-depth 
interviews 
Interview and focus groups conducted 
with community members, health care 
providers, government officials, 
representatives from nongovernmental 
organizations, and health professionals 
Fan et 
al., 
2016  
Pittsburgh, 
Pennsylvania, USA 
12 focus groups (84 total 
women) 18-30 years old 
Group discussion on preferred 
characteristics of an IVR with placebo and 
actual IVR available for examination 
Morrow 
Guthrie 
et al., 
2015 
Southeast New 
England, USA 
4 focus groups (21 women 
total) 18-45 years old. Used 
IVR in past 12 months 
Semi-structured focus groups to assess 
participants’ perceptions of their 
experience with the IVR 
Van et 
al., 
2012 
South Africa (Durban, 
Johannesburg, Cape 
Town) 
Tanzania (Moshi) 
157 HIV negative women 
used a placebo ring 6 focus 
groups (48 total women, 
18-35 years old). 19 
interviews with male 
partners 
Women received a placebo ring to wear 
for 12 weeks. A questionnaire was 
administered every 4 weeks to assess 
acceptability. Exit interview with focus 
groups were conducted to promote 
discussion. Male partners were contacted 
for participation with female permission. 
 
When considering the ease and accuracy of use, many women preferred an IVR that 
would be easily handled and inserted so as not to be “lost” during insertion; for this a certain 
level of opacity, size, and texture were desired for visual discernibility (Fan et al., 2016). 
Texture was a topic of debate among women as some argued a smooth, thin film would be 
easier to insert while others argued that some texture was necessary to prevent slippage 
through the fingers, detect adequate insertion, and prevent rapid dissolving of the medication 
(Morrow Guthrie et al., 2015). The effect of physical characteristics on the efficacy of the 
product was also commonly mentioned; participants associated porousness, opacity, and a 
square profile with increased drug delivery (Fan et al., 2016) and textured surfaces with a 
decreased likelihood of the involuntary expulsion of the IVR upon insertion (Morrow Guthrie 
et al., 2015). Of particular importance to the participants in the trial by Fan and colleagues 
(2016) was the maintenance of drug efficacy while inebriated as many of their higher-risk 
sexual encounters involved alcohol. This directly correlated with the participants desires for a 
drug with extended efficacy due to the possibility of sudden, unplanned sex (Fan et al., 2016). 
Considerations for user and, in particular, partner discretion, however, led participants to 
desire previously undesired traits: smoothness, thinness, and small size (Fan et al., 2016; 
Morrow Guthrie et al., 2015). Additional characteristics included being tasteless and odorless 
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to avoid detection by their partners (Fan et al., 2016). One particularly interesting point was 
the participants’ desires for a high concentration of drugs with regards to efficacy, but a low 
concentration with regards to minimizing the impact on the vagina due to their perception 
that an opaquer and thus more “concentrated” IVR would have a greater likelihood of 
discoloring vaginal fluid (Fan et al., 2016). The last theme identified by product assessment 
studies, impact on sex, highlights concerns about the product hampering sexual interest and 
its versatility in various types of sexual activity (Fan et al., 2016; Morrow Guthrie et al., 
2015). A summary of the main themes for an ideal IVR or microbicidal film and the 
respective characteristics for each theme obtained from the studies is listed in Table 4. 
 
Table 4. Compilation of preferred characteristics of an IVR or microbicidal film from various studies 
Major Themes Preferred Characteristics 
Accuracy and ease of 
use 
• Disparity between smooth and textured with regards to ease of insertion 
and detection of insertion1 
• Matte finish for ease of handling1,2 
• Translucent or opaque film for visibility1 
Desire for efficacy 
• Textured to prevent involuntary expulsion during use1 
• Effective when inebriated1 
• Porousness to facilitate drug delivery2 
• Square shape for greater coverage inside vagina1 
• Higher opacity for increased concentration1 
• Extended duration of use1,4 
Discretion 
• Tasteless/odorless/translucent or clear to avoid detection1 
• “Listerene pack size”1 
• Partner does not notice1,2,3 
• Smooth and thin to avoid detection by partner during sex1 
Minimal impact and 
comfort 
• Does not change natural color of vaginal fluid1 
• Smooth, thin, soft, flexible for comfort in vagina1,2 
Impact on sex 
• Conducive to all sexual activity types: oral, vaginal, anal1 
• Cannot be felt during sex1,2,3 
• Smooth, thin, and small for ease of insertion1,2 
• Avoid medicinal packaging1,4 
• Inoffensive taste for oral sex1 
• Portability to allow rapid, unplanned use1,3 
1(Fan et al., 2016) 2(Morrow Guthrie et al., 2015) 3(van der Straten et al., 2012) 4(Becker et al., 2004) 
 
 
In addition to documenting favorable characteristics through visual and manual 
inspections of sample IVRs, various clinical trials have been conducted to assess factors that 
	 	
	 Background – Exploring Intravaginal Ring Acceptability in Cape Town  – 17	–	
	
affect adherence to IVRs (Baeten et al., 2016; Nel, Bekker, et al., 2016; Nel, van Niekerk, et 
al., 2016). Throughout the 12-weeks, all three trials saw positive outcomes with over 95% of 
women describing the ring as comfortable and not being bothered by it during daily activities. 
Each trial, however, had women worried that the IVR could get “lost” in their body and 
experiencing difficulty removing the ring. An additional concern that was frequently 
documented in the clinical trials was the voluntary removal of the IVR. Although the research 
staff had advised the participants against the removal of the IVR, a small number of 
participants removed the ring, generally to clean it (Nel, Bekker, et al., 2016). A similar study 
exploring the acceptability and safety of a placebo IVR in 170 HIV-negative South African 
women aged 18 to 35 experienced similar issues with voluntary ring removal due to the 
misconception that the ring was to be cleaned during or after menses (Montgomery et al., 
2012). Both studies concluded that a more thorough explanation on this culturally sensitive 
topic would need to be provided. Another similar study of IVR adherence in women in 
Durban, Johannesburg, and Cape Town in South Africa and Moshi, Tanzania, participants 
indicated similar concerns; but minimized these concerns with study procedures that included 
explanations and demonstrations using a translucent pelvic model along with instructions on 
what to do if the ring were to come out (van der Straten et al., 2012). While proper insertion 
of the IVR was raised as a concern by study participants, insertion was not identified as a 
significant challenge, with 81% of the study participants able to successfully insert the IVR 
on their first attempt (van der Straten et al., 2012). 
Due to the unfamiliarity of the majority of the people residing in Cape Town with the 
IVR, an adequate prediction of women’s comfort with inserting the IVR cannot be obtained. 
However, the population’s familiarity, or lack thereof, with tampon use may correlate with 
the level of comfort women have inserting the IVR due to the similarity in insertion method. 
A study conducted at an urban reproductive health clinic in Durban, South Africa of 124 
women between the ages of 18 and 45 (most had completed secondary school, spoke isiZulu, 
been pregnant at least once, and half were not working or studying) found that 10.9% of 
participants reported using tampons as their main hygiene product, followed by 20.0% using 
tampons “usually,” and 43.6% never having used tampons before (Beksinska et al., 2015). 
The large disparity in the usage of sanitary protection is evident as “one in 10 African 
adolescent girls misses school during her period” (Euromonitor International, 2015, p. 1), 
likely because she cannot access products such as tampons and sanitary pads. Assuming that 
these data suggest a possible lack of experience with the insertion of tampons, the lack of 
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comfort with the administration of IVRs may pose an issue for the proper insertion of and 
adherence to the product. 
A multitude of clinical trials have been performed to measure adherence to the IVR 
through the lens of efficacy. However, due to the varying levels of adherence among study 
participants, the efficacy of the product has not been accurately measured. The inability of the 
clinical setting to accurately predict product efficacy was documented in the Vaginal and 
Oral Interventions to Curb the Epidemic (VOICE) study, which tested the effectiveness of 
ARVs in tablet and vaginal gel form (Stadler, Scorgie, van der Straten, & Saethre, 2016). 
Although the study participants reported good levels of adherence, the trial concluded that 
none of the products in the trial were effective in preventing HIV acquisition (Marrazzo et al., 
2015). Without proper adherence, the efficacy of the product will be substantially 
compromised, regardless of the theoretical efficacy of the product. In addition, the effect of 
clinical settings on the behavior of participants is well documented; the added health benefits, 
financial reimbursements, and sense of camaraderie are exclusive to clinical trials and do not 
accurately reflect a real-life setting. Furthermore, the inherent self-selection bias in clinical 
trials has been speculated to affect the results, as those who voluntarily participate in clinical 
trials are likely to possess a higher sense of resolve compared to those who do not participate 
(Stadler, Delany, & Mntambo, 2008). Therefore, an exploration of the various promoters and 
barriers to IVR adherence outside the context of a clinical setting is necessary to understand 
individual, interpersonal, environmental, community, societal, and economic factors that 
dictate IVR acceptability.  
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Methods 
 
This project was designed to explore IVR acceptability and accessibility preferences 
among at-risk populations residing in the Philippi township of Cape Town, South Africa in 
collaboration with the community organization, Sizakuyenza. In addition, we investigated the 
costs, distribution methods, and marketing strategies by interviewing stakeholders that would 
be involved in the implementation of a multipurpose IVR. By exploring the various factors 
that either promote or impede adherence to IVRs outside of a clinical setting, we investigated 
policies, programs, and considerations necessary to promote IVR adherence if the product 
were to be made available in South Africa. This project aimed to address the following 
objectives: 
 
1. Explore at-risk women’s perceptions, acceptability, and accessibility preferences of 
the IVR 
2. Explore men’s perceptions and acceptability of the IVR and the influence these 
perceptions may have on women’s acceptability of the product 
3. Investigate the costs, distribution methods, and marketing strategies associated with 
the IVR 
 
A mixed methods approach was used to address the stated objectives using various 
nonprobability sampling strategies to recruit participants. Our main method of inquiry was 
face-to-face, semi-structured interviews. Face-to-face interviews were the most favorable 
method as the circumstances dictate a more spontaneous response from the interviewee 
(Opdenakker, 2006). In addition, the interviewer can gather information from various social 
cues such as voice, intonation, and body language – information that could not be obtained 
through a phone or email interview (Opdenakker, 2006). However, the synchronous nature of 
face-to-face interviews that provide them with their advantages also require the interviewer to 
be much more engaged and concentrated on the questions to be asked and the answers given 
(Opdenakker, 2006). Wengraf (2001, p. 194) termed this added concentration as “double 
attention”: he explains that “[the interviewer] must both be listening to the informant’s 
responses to understand what he or she is trying to get at, and, at the same time, you must be 
bearing in mind your needs to ensure that all your questions are liable to get answered within 
the fixed time at the level of depth and detail that you need.” 
Methods	
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Semi-structured interviews are the most frequently used method of qualitative 
research. The nature of a semi-structured interview allowed our questions to be developed as 
we discovered more thematic areas. Similarly, questions that were not effective in previous 
interviews were removed from subsequent interviews. Both individual and group semi-
structured interviews were utilized. In individual interviews, the participant is able to 
communicate deeply about social and personal matters, compared to the group interview 
where it is unnatural to do so (DiCicco-Bloom & Crabtree, 2006). However, a group 
interview can be advantageous as it collects a wider range of experience from the participants 
(DiCicco-Bloom & Crabtree, 2006). 
 
Interviews with At-Risk Women and Men 
 We accomplished the first objective by conducting interviews with at-risk women 
who discussed their perceptions of the IVR as well as their thoughts regarding accessibility 
and convenience using the product through open-ended questions. We addressed the second 
objective by interviewing men in order to explore the male perspective of the IVR and how 
their perspectives affect female acceptability and accessibility. Interview questions were 
focused on individual experiences as well as understanding group opinions and community 
dynamics. Since every question may not have applied directly to the interviewee, the 
interviewee had the option to answer from a community perspective. All participants received 
20 ZAR (approximately 1.47 USD) for transportation and were served light refreshments as 
compensation for their participation in the study. An English-isiXhosa translator was 
arranged when the participant was unable to or uncomfortable with conducting the interview 
in English. 
 
Sampling Method 
 The primary sampling method was a convenience sample of participants met through 
our sponsoring organization, Sizakuyenza, that functioned as a pipeline to the surrounding 
community. Sizakuyenza is a non-profit organization located in the Philippi township that 
provides free health and wellness services to surrounding communities. Since its founding in 
2007 by the Western Cape Government, the organization has grown and expanded to create a 
large network of community members and staff (Western Cape Government, 2015). 
One of Sizakuyenza’s primary functions is to serve as a “House of Smiles,” a safe 
house for women experiencing domestic violence (Sizakuyenza, 2017). Some women seeking 
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refuge in the “House of Smiles” served as participants who provided us with insight on the 
acceptability of the IVR. Another one of Sizakuyenza’s major points of focus is its dedication 
to the HIV Prevention for Young Adolescents program (Sizakuyenza, 2017). Through 
various community outreach efforts, the prevention program connects the organization with 
members of at-risk populations. Additionally, Sizakuyenza commits itself to creating a strong 
network of South African women. Sizakuyenza’s health improvement efforts combined with 
its wide network gives the organization an established community presence. This provided 
connections with interview participants – mainly women, but also some men – within the 
community who participated in the interviews. Interviews took place during Sizakuyenza’s 
operational hours, 8h30 to 16h30. 
Our female interview sample represented a population that is most at risk of 
contracting HIV, which in the case of South Africa are young, black females (Shisana et al., 
2014). We focused on interviewing people aged 16 to 34. The lower age limit for our sample 
was chosen based on a study that gathered information from 1,149 women and 1,067 men 
about their sexual debuts (Richter, Mabaso, Ramjith, & Norris, 2015). The study found that 
over 25% of women in South Africa had their sexual debut prior to age 16, and over 40% of 
women in South Africa had their sexual debut prior to age of 18 (Richter et al., 2015). Since 
such a high percentage of women in South Africa have their sexual debut before the age of 
18, it was necessary to include women as young as 16 in our research in order to have a fully 
representative sample of the at-risk population. The upper age limit of our sample (34 years) 
was determined because black South African women aged 20 to 34 have a very high HIV 
prevalence (31.6%) (Shisana et al., 2014). We conducted interviews with women and men in 
order reach a point of thematic saturation (Guest, Bunce, & Johnson, 2006). 
 
Semi-Structured Interviews 
Prior to the start of the interview, the participant was asked to sign an informed 
consent form. The participant was made aware of his or her right to refuse to answer a 
question or halt the interview at any time. At the end of the consent form, the interviewee was 
asked whether or not he or she would allow the interview to be recorded. Throughout the 
interview, one group member served as the primary interviewer and the other as the primary 
note taker while they monitored the interview to ensure all the questions were addressed and 
interjected as necessary. The interviewers were divided according to gender, and the 
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interviewee was asked if he or she was comfortable interviewing with the pair of male or 
female interviewers. 
The semi-structured interview began with a discussion of the interviewee’s initial 
impressions of the IVR. Since the topics discussed in the interview portion of this method 
were delicate and personal, it was difficult to get interviewees to open up about their lives 
immediately. Instead of starting with personal questions, we asked questions about the IVR to 
open up a product-oriented line of questioning. The interviewers introduced the IVR, 
presented a placebo model of the device outside of the package for the interviewee to hold, 
and explained its functionality. After introducing the IVR, the interviewees were asked about 
their initial opinions on the product with, “What do you think of the IVR?” followed by, 
“What concerns do you have about the IVR?” The interviewers were able to probe the 
responses and get a deeper understanding of the meaning of the response. This insight was 
useful in understanding perceptions of the IVR in this project. Additionally, in the context of 
this project, this question was used as an ice-breaker and an opportunity to determine major 
concerns and misconceptions about the product.  
The remainder of the interview involved a series of thematic questions related to the 
acceptability of the IVR, including IVR characteristics, relationship dynamics, gender-based 
violence, stigma, socioeconomics, and distribution and cost preferences. Males had an 
adjusted interview to exclude female-oriented questions, but used the same thematic areas to 
understand the impact of male thoughts and opinions on female acceptability of the IVR. 
Relationship dynamics, gender-based violence, stigma, and socioeconomics were thematic 
areas identified to have a possible relationship with IVR acceptability as they are based on 
factors that increase the risk of health issues the IVR can prevent. Each interview lasted 
between 30 and 90 minutes and followed a list of open-ended questions. 
  
Demographic and Situational Questions 
At the end of each interview, participants were asked to answer a short questionnaire 
on demographics and situational circumstances. The demographic portion explored possible 
correlations between acceptability of the IVR and age (Kharsany & Karim, 2015; Shisana et 
al., 2014), relationship status (Shisana et al., 2014; Wand et al., 2011), occupation 
(Boonzaier, 2005; Gilbert & Walker, 2002; Strebel et al., 2006), and frequency of sexual 
activity. The situational questions explored factors that may affect the acceptability of the 
IVR, such as sexual activity, number of children, desire to get pregnant, and type of 
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contraception used, if any. Female participants were asked additional situational questions 
that may affect IVR acceptability, such as products used during menstruation as a measure of 
comfort and familiarity inserting the IVR. The demographic and situational questions were 
asked at the end of the interview to prevent modified responses or bias from early exposure to 
factors relevant to the analysis of the data (Sinclair, Hardin, & Lowery, 2006). 
 
Interviews with External Stakeholders Involved in Implementation of the IVR 
To address the third objective, face-to-face and phone interviews with various 
stakeholders that will likely have an influence on the successful implementation of the IVR in 
Cape Town were conducted. Stakeholders included government officials, NGO 
representatives, local health care providers, and professors. A list of the individuals that were 
interviewed are categorized according to their influence on the implementation of the IVR 
and compiled in Table 5. The organization was categorized into either policy makers and 
policy influentials, or health care providers, based on their field of work. Due to 
transportation and time constraints, scheduling face-to-face interviews was not always 
feasible; therefore, phone interviews were conducted as a secondary option. The phone 
interview required a similar level of engagement and concentration as the face-to-face 
interview (Wengraf, 2001). Although the exact response of the interviewee differed 
according to the method of inquiry, the same analytical methods were utilized to analyze data 
from the two forms of interviews. 
 
Table 5. Organizations of interviewees interviewed categorized according to their field of work. Names of individual 
representatives are excluded for purposes of confidentiality. 
Organization Category Influence 
City of Cape Town 
Health Department 
Policy 
maker/influential 
Provide range of primary health care: municipal health 
(environmental health) services and personal primary health 
service options, to all residents through network of clinics and 
other health care facilities. 
 
Desmond Tutu HIV 
Foundation 
Policy 
maker/influential 
Involved in research, treatment, training and prevention of HIV 
and related infections in southern Africa. 
 
University of Cape 
Town 
 
Policy 
maker/influential 
Involved in public health research and related technology 
research 
TB/HIV Care 
Association 
Health services 
provider 
Prevent, find, and treat HIV and TB in the general population as 
well as in key groups such as inmates, sex workers and people 
who inject drugs. 
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We used a purposive sampling strategy to identify appropriate individuals to 
interview. This strategy was also used by Becker and colleagues (Becker et al., 2004) in their 
study on the introduction of microbicides in South Africa. Purposive sampling allowed for 
the “identification and selection of information-rich cases for the most effective use of 
limited resources” (Palinkas et al., 2015, p. 2). By focusing on a specific population, we 
identified interviewees that were most likely to enable us to answer our research questions 
(Lærd Dissertation, 2012). This, however, was difficult due to the constraints set by the 
seven-week time frame. To address this possible lack of data, a snowball sampling method 
was simultaneously employed to establish relationships with influential individuals and 
organizations suggested by previous interviewees that we may not have met otherwise. 
Although this strategy was useful to obtain a greater quantity of data, the tendency for 
interviewees to suggest other possible interviewees with similar characteristics presented bias 
that required consideration in our analysis (Palinkas et al., 2015). As a result, the effects of 
selection biases were considered and individuals and organizations with contrasting 
viewpoints and missions were represented in the data. In order to establish contact with 
various individuals and organizations, we emailed either the individual or the organization 
initially and organized a location and time for the interview. We also attended the 2017 
AIDSImpact conference from the 13th to 15th of November to integrate ourselves into the 
current conversations and network with scholars and implementers with similar lines of 
inquiry. Through this conference, we were able to expand our network and organize 
additional interviews. 
 
Semi-Structured Interviews 
Prior to the start of the interview, the informed, verbal consent of the interviewee 
was obtained and the interviewee was made aware of his or her right to refuse to answer a 
question or halt the interview at any time. Then, the verbal consent to audio-record the 
interviews was requested. As all the interviewees provided their consent to be recorded, an 
audiotape recorder was used to record the dialogue while notes were taken simultaneously. 
The semi-structured interviews revolved around three thematic areas and its impact on 
the introduction of the IVR to Cape Town: cost, distribution methods, and marketing 
strategies. These thematic areas were heavily discussed by Becker and colleagues (2004) and 
are the main sources of influence that affect the perception, acceptability, and accessibility of 
the product to potential female users and their male partners in the target population. Unlike 
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the interviews with the at-risk populations, each stakeholder interview required a different set 
of open-ended questions and topics of discussion tailored according to the area of expertise of 
the interviewee, which then led to the emergence of other questions that continued to carry 
the dialogue between the interviewer and interviewee (DiCicco-Bloom & Crabtree, 2006). 
Due to the semi-structured nature of the interviews, the interviews varied in length from 40 
minutes to 80 minutes. The thematic areas, sub-topics, and questions are illustrated in Figure 
6: the green represents major themes, blue represents sub-topics within the themes, and 
purple represents the various questions and considerations associated with the sub-topics. 
 
Figure 5. Breakdown of IVR acceptability in themes, sub-topics, and questions 
The time and location of the interviews was based on the convenience and availability 
of the team members and the interviewee. Since the data was not time-sensitive, the 
interviews were conducted during the operational hours of the interviewee’s organization. If 
the interviewee was unable to schedule a face-to-face interview and the interviewee was still 
willing to participate, the possibility of a phone interview was suggested. At least two 
members of the team were present during each interview and the same data collection 
strategy was used. 
Due to the short time frame, interviews were rapidly conducted with a variety of 
contacts. Since this method was focused on gathering specific information regarding cost, 
accessibility, and marketing strategies from various stakeholders, data saturation was not 
considered when determining an adequate sample size; rather, the importance of this method 
was selecting key individuals and organizations that will influence IVR implementation. Prior 
to scheduling a large number of interviews, the time required to transcribe each interview was 
considered. 
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Data Analysis 
A modified grounded theory approach was used to analyze interview notes and 
transcripts, identifying themes and adapting them to account for new and different data. The 
modified grounded theory technique allows researchers to find themes and patterns within the 
data (Corbin & Strauss, 2014). This analysis technique helped to avoid preconceptions 
(Martinez Perez, Mubanga, Tomas Aznar, & Bagnol, 2015) and instead rely mostly on the 
information presented in the interviews. However, we began our analysis with expected 
themes such as cost, stigma, and relationship dynamics, among others, that were identified 
through our research, allowing for additional themes to emerge. 
 Transcriptions were analyzed by formulating a codebook and tagging elements of text 
by code (Coffey & Atkinson, 1996). The codes were used to sort content and generate 
thematic areas. Transcriptions were periodically revisited to update codes as more thematic 
areas were discovered and understood. Once themes and interests were identified, they were 
sorted together and compared against each other. The similarities and differences among 
responses in specific categories were noted and analyzed to understand what made them 
similar or different.  
  
Ethical Considerations  
	 In all our interviews, we remained conscious of four ethical concerns that can be 
applied to the project: reducing the risk of unanticipated harm, protecting the interviewee’s 
information, effectively informing interviewees about the study, and reducing the risk of 
exploitation (DiCicco-Bloom & Crabtree, 2006). The risk of unanticipated harm was a 
primary issue due to the nature of the participants and the questions that were asked. Factors 
relevant to research such as HIV and STI history and unplanned pregnancies may have been 
uncomfortable for participants to discuss; however, the interviewers were prepared to sense 
distress and move the interview forward to minimize distress for the interviewees. Prior to the 
start of every interview, the interviewees were informed about the study and were required to 
provide their informed consent. Interviewees were also made aware at the start of the 
interview that they had the right to refuse to answer any question or disengage from the 
interview at any time. Information that was communicated through interviews was protected 
due to the sensitive data that was collected. All data were stored in password-protected 
folders and was only accessible to members of the team, but is available to the sponsors, 
project advisors, or the Worcester Polytechnic Institute Institutional Review Board if the 
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circumstances require it. The confidentiality of the participants is also maintained in the 
report. The names and any other details that may identify an interviewee are not mentioned in 
the report or in any presentations without the prior consent of the individual. Reducing 
exploitation was a minor consideration in the context of this project considering that all 
participation was voluntary and consensual. 
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Results 
 
Study Participants 
In total, 28 black individuals (22 females and 6 males) were interviewed at 
Sizakuyenza. Twenty of the 22 female interviews were conducted individually, with one 
group interview of two women. Three of the six males were interviewed individually, with 
one group interview of three men. One female participant exceeded our maximum age limit 
of 35 and was excluded from our analysis. In addition, one female participant chose not to 
answer the demographics survey; however, her responses were used in our analysis. One 
male participant did not complete the demographics questionnaire in its entirety as he omitted 
occupation and number of sexual partners in the last three months. Although not represented 
in our demographics or included in our analysis, we also conducted a group interview of 15 
women and 2 men, which served to confirm our findings from our individual interviews. 
Participant demographics and behavioral characteristics are shown in Table 6. 
 
Table 6. Participant demographics for semi-structured interviews with at-risk community members 
Variable Female (n=20) Male (n=6) 
 Number of Responses (%) 
Employment status   
     Employed 9 (45) 2 (40) 
     Unemployed 10 (50) - 
     Student 1 (5) 3 (60) 
Relationship status   
     Married 4 (20) 2 (33) 
     Single 9 (45) 2 (33) 
     In a relationship 7 (35) 2 (33) 
Preferred contraceptive   
     Condom 11 (55) - 
     Female condom 1 (5) - 
     Birth control pills 2 (10) - 
     Depot-Provera shot 2 (10) - 
     Implant 1 (5) - 
     None 3 (15) - 
Sex without condom in last 3 months 9 (45) 2 (33) 
Trying to get pregnant 3 (15) 1 (17) 
Preferred menstruation product   
     Sanitary pads 17 (85) - 
     Tampons 1 (5) - 
     None 2 (10) - 
 
Variables 
 
Mean (SD)  
Age  28.7 (4.3) 24.2 (9.0) 
Number of children 1.8 (1.0) 0.5 (0.6) 
No. sexual partners in the last 3 months  0.9 (0.5) 2.0 (3.4) 
Results	
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Key Findings 
Consistent with prior findings, our data suggest that the multi-purpose IVR could 
address ongoing concerns around inconsistent condom use (Statistics South Africa, 2017) and 
the influence of relationship dynamics and roles on negotiating and acquiring various forms 
of contraception and disease prevention products (Maharaj & Cleland, 2004; Pettifor et al., 
2004; United Nations, 2015). In addition, our data show the limited use of intravaginal 
products in the study population, including female condoms and tampons, also consistent 
with prior observations (Beksinska et al., 2001; Beksinska et al., 2015). This could negatively 
influence product use as a lack of female familiarity with vaginal insertion may correlate with 
a lack of female comfort with IVR insertion. Our data indicate that the novelty of the product 
and the confines of its distribution may affect its utilization, and consequently its efficacy at 
reducing HIV and STI incidence, and preventing unplanned pregnancy at a population level. 
 
Inconsistent and Undesirable Condom Use 
Theoretically, the advantage of the IVR is that it places the control (and burden) of 
disease prevention and pregnancy planning on the female (Thurman et al., 2013). While 
contraceptive products that provide women with management over pregnancy are available, 
currently, STI and HIV prevention is limited to negotiated female or male condom use 
(Pettifor et al., 2004). Our data indicate that, in the study population, condom use is highly 
undesirable, with one male participant explaining, “Some say the condom breaks, some say 
they don’t feel flesh-to-flesh, having sex how they want to. They want to feel that friction” 
(M1). Furthermore, female interviewees shared stories of men deliberately breaking condoms 
during sex just so they could get women pregnant further supporting the ineffectiveness of 
the male condom at protecting women from various STIs as well as pregnancy. 
 
Influence of Relationship Dynamics on Product Negotiation and Acquisition 
The multipurpose IVR offers women the ability to manage their disease risk, 
discreetly, if they choose. In several interviews, female participants confirmed that the 
discrete nature of the product is ideal, explaining how “it’s perfect” that she would be the 
only one to “know what is happening in [her] body.” Despite study participants’ positive 
impressions of the capability for discretion, most participants indicated that they would likely 
communicate with their partners about product use. Married men and women, in particular, 
felt strongly about communication being an important factor in ensuring IVR acceptability. In 
contrast, unmarried men and women agreed that the women had less of an obligation to 
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discuss disease prevention and contraception with their sexual partners due to the volatility of 
their relationships, although some said they would disclose product use anyway. As noted by 
one male interviewee, these considerations of product negotiation are in line with accepted 
relationship roles, noting “those who are single, they have the advantage of making their own 
decisions. Those who are married, they have to first sit down and explain whatever decision 
they are going to take” (M6). Some study participants noted concerns over assumptions of 
infidelity, if such a product was used without first discussing its use, as one female 
participant pointed out, “He is going to be like ‘You didn’t tell me’, he is going to think you 
are sleeping with other men and then if you tell him late he going to be angry, ‘You didn’t tell 
me you were using this without my confirmation’” (W16). In spite of this concern, several 
male and female interviewees pointed out that men usually do not care what disease 
prevention or contraception women use because they themselves will appreciate additional 
protection, especially in the absence of condom use. 
The effect of relationship roles extends beyond negotiations of product use to 
concerns around product acquisition. As explained by a senior pharmacist at the City of Cape 
Town Department of Health, given the nature of the product and the likelihood that in order 
to enter the public marketplace, it will require significant state and private subsidies and is 
unlikely to be available without a prescription, the product will only be available at regulated 
dispensary locations (i.e., pharmacies and hospitals). This may pose a barrier to accessibility 
as our data reveal significant dislike for doctors and hospitals given prior negative 
experiences with health care providers. As explained by participants, with regards to the 
dissemination of contraception and disease prevention products, health care providers lack 
discretion and sensitivity, with nurses calling on patients by name and reason for their clinic 
visit in the waiting area. Such publicizing of private information is particularly problematic in 
a context where expectations of marriage are linked to child production and the undisclosed 
use of disease prevention and contraceptive methods is highly stigmatized. As expressed by 
one female participant, “If you go to the public hospital, they will just say, ‘Family planning, 
this side.’ Then, if you are married and you will be seen in the family planning side, it’s going 
to be bad” (W18). In addition to addressing discretion, clinics will also have to consider 
potential increases in service utilization, and as such need to address existing barriers to 
access including long wait times, associated travel costs and work time lost, and limited 
patient-provider engagement, as described “[you need to] go with your own information, 
[because] they don’t have time to explain to you the options for prevention contraceptives” 
(W18). 
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Effects of Exposure to Intravaginal Products on Comfort with IVR Insertion 
 Limited engagements with health care providers offers one explanation for limited 
exposure to and experience with products we deemed related to the IVR (those that require 
vaginal insertion – tampons and female condoms). Confirming the limited use of tampons 
that was found at an urban reproductive health clinic in Durban (Beksinska et al., 2015), our 
study population had limited experience with tampons, explaining that they “fear that the 
tampon will get stuck inside” and that it would be “very uncomfortable.” Other women 
explained that they had never considered using tampons because they had been “raised using 
pads.” While cost may be a barrier to tampon use, it was not mentioned by study participants, 
and price estimates indicate no significant differences in product costs (per product estimate 
from Clicks: pads 2.10 ZAR; tampons 2.70 ZAR, approximately 0.15 USD and 0.20 USD, 
respectively). Study participants were familiar with the female condom, but again, few had 
experience using the product. Some demonstrated a theoretical understanding of the insertion 
strategy of the female condom and its similarity to the IVR insertion approach – squeezing 
the inner ring which will expand within the vagina. A medical officer involved in an IVR 
clinical trial at the Desmond Tutu HIV Foundation (DTHF) suggested that greater exposure 
to medical providers that corresponds with age and life experiences influences willingness to 
insert products like the IVR. She further noted that in an ongoing IVR clinical trial, older 
female study participants “have had babies, they’ve had pap smears, things in and out of 
their vaginas,” making them more comfortable with vaginal insertion compared to their 
younger study counterparts. However, women’s familiarity or experience with tampons and 
female condoms have not been associated with their level of comfort with the IVR, due to the 
limited number of women using these products. 
 
Novelty of the Product and the Confines of its Distribution May Affect its Utilization 
Given the current conceptualization of the product, correct usage and adherence will 
significantly influence efficacy. The importance of correct usage and adherence has been 
demonstrated through the lowered levels of efficacy seen in clinical trials due to adherence-
related issues; however, the clinical trials have not been able to identify the drivers affecting 
adherence. In addition, the product is still novel in this study population, and as such, various 
design considerations should be taken into account to ensure appropriate usage. The ongoing 
clinical trial assessing dapivirine IVRs in multiple study sites (Nel, van Niekerk, et al., 2016) 
found that participants were initially uncomfortable using the ring, limiting adherence and 
lowering product effectiveness. Consequently, exposure strategies have been implemented to 
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improve comfort levels including access to professionals who can insert the product for the 
study participant as well as hosting participant support groups to discuss product concerns. 
Beyond the confines of a clinical trial, several study participants reflected a similar idea, 
advocating for a prescription requirement which would accompany a visit to a professional to 
obtain specific usage directions and assistance. Having no familiarity with such a product, 
our study population expressed concerns about product removal, consistent with findings 
from other studies (Montgomery et al., 2012; Nel, van Niekerk, et al., 2016; van der Straten 
et al., 2012). 
In addition, concerns were raised about product use during menstruation, as 
documented in clinical trials during which participants voluntarily removed the IVR during 
menses, generally to clean it (Montgomery et al., 2012; Nel, Bekker, et al., 2016). 
Furthermore, the DTHF medical officer involved in an IVR safety and efficacy trial discussed 
how female participants in the study would share their IVR with their peers in greater need of 
protection. For example, if a friend of the study participant was more likely to have sexual 
intercourse that night, then the IVR would be lent out. There has also been some anecdotal 
evidence that in an effort to extend the life of the product, the IVR was removed and inserted 
only when it is deemed necessary for protection, following the more familiar use dynamics of 
condoms. Finally, as noted by a postdoctoral scholar at the DTHF, should the product alter 
menstruation patterns (a common occurrence with hormonal contraception), users must be 
well informed as they may discontinue use assuming accidental pregnancy. 
These alternative use dynamics reflect not only the novelty of having a product 
inserted into the body for prolonged periods of time but also ongoing economic influencers. 
Different potential usage patterns reflect a desire to save money by sharing the product with 
friends, or extending the duration of the product past the efficacy period of three to four 
weeks. Given that a constant exposure to ARVs as well as hormonal medication is necessary 
for the IVR to be effective (Thurman et al., 2013), removing the product would compromise 
product efficacy. However, an investigation of the levels of protection offered at various time 
intervals post-removal is necessary to further confirm such pharmacokinetics. Alternatively, 
product developers may need to consider products that have more familiar usage 
characteristics, such as single-use (possibly 24-hour) products that are equally discrete and 
female-initiated. 
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Discussion 
 
Overall acceptability for the multi-purpose IVR was very high among our 
interviewees despite the sub-optimal levels of comfort and experience with vaginal product 
insertion. Based on the information provided in interviews with the at-risk population and 
stakeholders, insertion appears to be a significant obstacle that may hinder acceptance of the 
IVR, particularly for younger women. Familiarity, and more importantly, experience with 
related intravaginal products such as tampons and female condoms may decrease insertion-
related fears. However, a more thorough investigation into women’s use of and familiarity 
with various vaginal products in South Africa must be conducted to support such a causal 
relationship. The positive responses to the product despite the lack of intravaginal product 
insertion familiarity and experience may be attributable to the protection that the IVR offers 
against STIs and pregnancy. The possible benefits of the product may have negated any 
insertion-related uncertainties among the participants. 
Although pharmacies, clinics, and hospitals can adequately offer the necessary 
resources for the distribution of the IVR, its fixed location provides a barrier to those without 
the necessary transportation accommodations or availability. A program manager from 
TB/HIV Care Association mentioned the inability of youth attending schools to access health 
care due to the alignment of times attending school with the open hours of the clinics. To 
address this, she suggested the possibility of a mobile site – a mobile clinic overseen by a 
registered nurse with a dispensing license on board that runs specific routes and fills scripts. 
She mentioned that such a distribution scheme would increase the accessibility to the product 
for those unable to travel to a fixed site because of financial or time-related constraints. With 
the mobile site, users would still face the barrier of having to visit a doctor to receive a 
prescription. However, they could receive IVRs from the mobile site for the duration of their 
prescription, or receive a refillable prescription that would just require collecting the product 
from the pharmacy periodically for a pre-determined duration. 
Throughout our interviews with men and women at Sizakuyenza, as well as 
consultations with external stakeholders, the recurring theme of information dissemination 
was emphasized as the key to promoting the correct usage of, adherence to, and acceptability 
of the IVR. At first glance, information dissemination presents itself as a powerful tool 
capable of addressing the issues of STIs, HIV, and unintended pregnancy with results that 
support its positive impact (Kirby, Laris, & Rolleri, 2007). However, as explained earlier, a 
Discussion	
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variety of individual, interpersonal, socioeconomic, and environmental factors must also be 
accounted for in the decision-making process of those in at-risk communities. Rational choice 
theory assumes that, given a set of constraints, the individual chooses the optimal option 
(Green, 2002); however, potential users of the IVR face constraints that may make the 
rational choice one that does not involve obtaining and using the IVR. To promote adherence 
among such a population, information dissemination alone is not sufficient. An investment 
has to be made into improving existing and developing new social infrastructure that serves 
to promote the use of and adherence to new medical technologies such as the IVR. 
Our data support existing evidence that young females are an ideal target population 
to market the IVR to in South Africa, as they make up the highest HIV prevalence in the 
country (Shisana et al., 2014). However, product marketing should not be limited to females, 
as our data indicate that males, especially in married partnerships, should be engaged in 
conversations around product options and use. Furthermore, to limit product stigmatization, 
perceptions that only ill people (product medicalization as identified by Becker et al., 2004) 
and people engaging in risky behaviors should use the product, the product needs to be 
marketed in a way that conveys notions of health and responsibility as opposed to illness, 
carelessness, and promiscuous behavior. 
Social media was repeatedly identified as a promising medium through which 
information regarding new products such as the multipurpose IVR could be disseminated. Of 
the mentioned social media platforms, Facebook was most popular while Instagram, 
WhatsApp, and YouTube were mentioned as well. Social media is a promising avenue to 
market the product given the high percentage of the South African population on social 
media. Applications such as Facebook, YouTube, and WhatsApp are the three most popular 
social media platforms in South Africa and may serve as an invaluable medium to 
disseminate information on the IVR (Qwerty, 2017). In addition, the target population for the 
IVR (young women) is also the second largest age group of Facebook consumers in South 
Africa (second only to their male counterparts), with a total of 5 million Facebook users 
being between ages 18 and 34 (Qwerty, 2017). Given the large presence of youth on social 
media platforms, this online medium is the most advantageous avenue to inform younger 
populations on technologies such as the IVR.  
Another viable option suggested by stakeholders from the Department of Health is 
marketing in a topic-related setting referred to as “outreach” stations or “gazebos,” where 
communities are offered various disease prevention and contraception products, education on 
proper usage of these products, and HIV counseling and testing. Participants in our study also 
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stressed the importance of community dialogue and community leader acceptance of the 
product, due to the strong influence of community leaders’ decisions on community 
members. The final method suggested by participants and multiple stakeholders is to educate 
students about the product directly in school. Education about the IVR would be relevant in a 
class participants and stakeholders referred to as “Life Orientation,” which covers topics such 
as family planning, pregnancy, STIs, and related topics. This approach would solely target 
the youth, but also presents several other advantages. Presenting the IVR in schools would 
allow both males and females to learn about the product together, which would both be 
acceptable and effective according to participants from our study. One participant pointed out 
that this will be especially effective if there are sexually active students in the classroom who 
can promote discussions with their peers. 
One potential limitation of this study pertains to the characteristics of the sample 
population as several participants were employees of Sizakuyenza, or members of the 
community with strong ties to the organization. The study participants’ involvement with the 
organization that promotes sexual and reproductive health, may have influenced their 
responses. In addition, their employment with Sizakuyenza may suggest an altered risk 
profile, mainly due to their higher economic status compared to unemployed community 
members. This is further supported by one participant whose responses suggested a greater 
risk for acquiring STIs and becoming pregnant compared to the majority of our interviewees 
due to her lack of power in negotiating contraceptive and disease prevention use with her 
partner. Although her circumstances categorize her as an outlier in our data, she mentioned 
that her situation is common among women in her community claiming that “9 out of 10 
women in Xhosa tribes” (W18) were experiencing similar circumstances – this led us to 
believe that we may not have been able to interview a particularly high-risk population in the 
community. In addition, due to logistical constraints, we were unable to obtain a consistent 
translator to assist us during our interviews. As some of the translators were previous 
interviewees, their pre-exposure to the questions may have presented an unexpected source of 
bias. The seven-week time frame imposed another limitation as we were unable to conduct a 
large number of interviews to uncover any significant correlations with our demographics. 
Lastly, our personal limitations due to a lack of experience discussing and probing 
participants on sensitive topics such as these may have hindered our ability to inquire about 
the deep-seated drivers of IVR adherence. 
Based on the limitations identified in our study, future directions should focus on 
conducting studies with an extended time frame and an expanded study population. In 
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addition, separate studies that more specifically investigate the relationship between female 
intravaginal product familiarity and experience with IVR insertion comfortability may need 
to be conducted to properly understand this relationship. 
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Conclusion 
  
 The IVR is a novel technology with the potential to address major public health issues 
in South Africa. However, an understanding of the various promoters and impeders to IVR 
adherence, which will ultimately influence its effectiveness, has not been explored 
thoroughly and is necessary to advise the development and introduction of the product. Our 
project identified various individual, social, economic, and political factors through 
interviews with members of an at-risk population and external stakeholders that will likely 
influence acceptability and accessibility of the IVR. In the context of the biotechnology 
industry, this project highlights the importance of interdisciplinary work. When developing 
medical technologies, the design of the product must be advised by the investigation and 
exploration of the context under which it will be utilized. With the advent of user-centered 
design, product developers must remain conscious of the constraints placed by various social, 
environmental, economic, and interpersonal factors in order for products to have their desired 
effect. 
	
 
  
Conclusion	
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